Global Sugammadex Sodium API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Sugammadex Sodium API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 119

Published Date: 04 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Sugammadex Sodium API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Sugammadex Sodium API market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Sugammadex Sodium API market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Injection occupied for % of the Sugammadex Sodium API global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, 0.99 segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Sugammadex Sodium API include Transo-Pharm, Rochem International, Dr. Reddy's Laboratories, Extrovis AG and Teva API, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Sugammadex Sodium API market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Sugammadex Sodium API manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Sugammadex Sodium API market based on the following parameters – headquarters, production locations, products portfolio, Sugammadex Sodium API revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Sugammadex Sodium API market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Sugammadex Sodium API market is split by Purity and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity (2017-2028; USD Million)
0.99
0.995
Others

Market segment by Application (2017-2028; USD Million)
Injection
Others

The key market players for global Sugammadex Sodium API market are listed below:
Transo-Pharm
Rochem International
Dr. Reddy's Laboratories
Extrovis AG
Teva API
Piramal Pharma Solutions
ASolution Pharmaceuticals
BrightGene Bio-Medical Technology
Epoch Labs
Lek Pharmaceuticals
MSN Laboratories
Mankind Pharma
Mylan Inc
Solara Active Pharma Sciences
Viwit Pharmaceuticals
Yonsung Fine Chemicals

Region Segment (2017-2028; USD Million)
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sugammadex Sodium API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sugammadex Sodium API, with price, sales, revenue and global market share of Sugammadex Sodium API from 2019 to 2022.
Chapter 3, the Sugammadex Sodium API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sugammadex Sodium API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sugammadex Sodium API market forecast, by regions, purity and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sugammadex Sodium API.
Chapter 13, 14, and 15, to describe Sugammadex Sodium API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Sugammadex Sodium API Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Sugammadex Sodium API Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 0.99
1.2.3 0.995
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sugammadex Sodium API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Injection
1.3.3 Others
1.4 Global Sugammadex Sodium API Market Size & Forecast
1.4.1 Global Sugammadex Sodium API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sugammadex Sodium API Sales in Volume (2017-2028)
1.4.3 Global Sugammadex Sodium API Price (2017-2028)
1.5 Global Sugammadex Sodium API Production Capacity Analysis
1.5.1 Global Sugammadex Sodium API Total Production Capacity (2017-2028)
1.5.2 Global Sugammadex Sodium API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sugammadex Sodium API Market Drivers
1.6.2 Sugammadex Sodium API Market Restraints
1.6.3 Sugammadex Sodium API Trends Analysis

2 Manufacturers Profiles
2.1 Transo-Pharm
2.1.1 Transo-Pharm Details
2.1.2 Transo-Pharm Major Business
2.1.3 Transo-Pharm Sugammadex Sodium API Product and Services
2.1.4 Transo-Pharm Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Rochem International
2.2.1 Rochem International Details
2.2.2 Rochem International Major Business
2.2.3 Rochem International Sugammadex Sodium API Product and Services
2.2.4 Rochem International Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dr. Reddy's Laboratories
2.3.1 Dr. Reddy's Laboratories Details
2.3.2 Dr. Reddy's Laboratories Major Business
2.3.3 Dr. Reddy's Laboratories Sugammadex Sodium API Product and Services
2.3.4 Dr. Reddy's Laboratories Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Extrovis AG
2.4.1 Extrovis AG Details
2.4.2 Extrovis AG Major Business
2.4.3 Extrovis AG Sugammadex Sodium API Product and Services
2.4.4 Extrovis AG Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva API
2.5.1 Teva API Details
2.5.2 Teva API Major Business
2.5.3 Teva API Sugammadex Sodium API Product and Services
2.5.4 Teva API Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Piramal Pharma Solutions
2.6.1 Piramal Pharma Solutions Details
2.6.2 Piramal Pharma Solutions Major Business
2.6.3 Piramal Pharma Solutions Sugammadex Sodium API Product and Services
2.6.4 Piramal Pharma Solutions Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ASolution Pharmaceuticals
2.7.1 ASolution Pharmaceuticals Details
2.7.2 ASolution Pharmaceuticals Major Business
2.7.3 ASolution Pharmaceuticals Sugammadex Sodium API Product and Services
2.7.4 ASolution Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BrightGene Bio-Medical Technology
2.8.1 BrightGene Bio-Medical Technology Details
2.8.2 BrightGene Bio-Medical Technology Major Business
2.8.3 BrightGene Bio-Medical Technology Sugammadex Sodium API Product and Services
2.8.4 BrightGene Bio-Medical Technology Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Epoch Labs
2.9.1 Epoch Labs Details
2.9.2 Epoch Labs Major Business
2.9.3 Epoch Labs Sugammadex Sodium API Product and Services
2.9.4 Epoch Labs Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lek Pharmaceuticals
2.10.1 Lek Pharmaceuticals Details
2.10.2 Lek Pharmaceuticals Major Business
2.10.3 Lek Pharmaceuticals Sugammadex Sodium API Product and Services
2.10.4 Lek Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MSN Laboratories
2.11.1 MSN Laboratories Details
2.11.2 MSN Laboratories Major Business
2.11.3 MSN Laboratories Sugammadex Sodium API Product and Services
2.11.4 MSN Laboratories Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mankind Pharma
2.12.1 Mankind Pharma Details
2.12.2 Mankind Pharma Major Business
2.12.3 Mankind Pharma Sugammadex Sodium API Product and Services
2.12.4 Mankind Pharma Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Mylan Inc
2.13.1 Mylan Inc Details
2.13.2 Mylan Inc Major Business
2.13.3 Mylan Inc Sugammadex Sodium API Product and Services
2.13.4 Mylan Inc Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Solara Active Pharma Sciences
2.14.1 Solara Active Pharma Sciences Details
2.14.2 Solara Active Pharma Sciences Major Business
2.14.3 Solara Active Pharma Sciences Sugammadex Sodium API Product and Services
2.14.4 Solara Active Pharma Sciences Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Viwit Pharmaceuticals
2.15.1 Viwit Pharmaceuticals Details
2.15.2 Viwit Pharmaceuticals Major Business
2.15.3 Viwit Pharmaceuticals Sugammadex Sodium API Product and Services
2.15.4 Viwit Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Yonsung Fine Chemicals
2.16.1 Yonsung Fine Chemicals Details
2.16.2 Yonsung Fine Chemicals Major Business
2.16.3 Yonsung Fine Chemicals Sugammadex Sodium API Product and Services
2.16.4 Yonsung Fine Chemicals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Sugammadex Sodium API Breakdown Data by Manufacturer
3.1 Global Sugammadex Sodium API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sugammadex Sodium API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sugammadex Sodium API
3.4 Market Concentration Rate
3.4.1 Top 3 Sugammadex Sodium API Manufacturer Market Share in 2021
3.4.2 Top 6 Sugammadex Sodium API Manufacturer Market Share in 2021
3.5 Global Sugammadex Sodium API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sugammadex Sodium API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Sugammadex Sodium API Market Size by Region
4.1.1 Global Sugammadex Sodium API Sales in Volume by Region (2017-2028)
4.1.2 Global Sugammadex Sodium API Revenue by Region (2017-2028)
4.2 North America Sugammadex Sodium API Revenue (2017-2028)
4.3 Europe Sugammadex Sodium API Revenue (2017-2028)
4.4 Asia-Pacific Sugammadex Sodium API Revenue (2017-2028)
4.5 South America Sugammadex Sodium API Revenue (2017-2028)
4.6 Middle East and Africa Sugammadex Sodium API Revenue (2017-2028)

5 Market Segment by Purity
5.1 Global Sugammadex Sodium API Sales in Volume by Purity (2017-2028)
5.2 Global Sugammadex Sodium API Revenue by Purity (2017-2028)
5.3 Global Sugammadex Sodium API Price by Purity (2017-2028)

6 Market Segment by Application
6.1 Global Sugammadex Sodium API Sales in Volume by Application (2017-2028)
6.2 Global Sugammadex Sodium API Revenue by Application (2017-2028)
6.3 Global Sugammadex Sodium API Price by Application (2017-2028)

7 North America by Country, by Purity, and by Application
7.1 North America Sugammadex Sodium API Sales by Purity (2017-2028)
7.2 North America Sugammadex Sodium API Sales by Application (2017-2028)
7.3 North America Sugammadex Sodium API Market Size by Country
7.3.1 North America Sugammadex Sodium API Sales in Volume by Country (2017-2028)
7.3.2 North America Sugammadex Sodium API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Purity, and by Application
8.1 Europe Sugammadex Sodium API Sales by Purity (2017-2028)
8.2 Europe Sugammadex Sodium API Sales by Application (2017-2028)
8.3 Europe Sugammadex Sodium API Market Size by Country
8.3.1 Europe Sugammadex Sodium API Sales in Volume by Country (2017-2028)
8.3.2 Europe Sugammadex Sodium API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Purity, and by Application
9.1 Asia-Pacific Sugammadex Sodium API Sales by Purity (2017-2028)
9.2 Asia-Pacific Sugammadex Sodium API Sales by Application (2017-2028)
9.3 Asia-Pacific Sugammadex Sodium API Market Size by Region
9.3.1 Asia-Pacific Sugammadex Sodium API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sugammadex Sodium API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Purity, and by Application
10.1 South America Sugammadex Sodium API Sales by Purity (2017-2028)
10.2 South America Sugammadex Sodium API Sales by Application (2017-2028)
10.3 South America Sugammadex Sodium API Market Size by Country
10.3.1 South America Sugammadex Sodium API Sales in Volume by Country (2017-2028)
10.3.2 South America Sugammadex Sodium API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Purity, and by Application
11.1 Middle East & Africa Sugammadex Sodium API Sales by Purity (2017-2028)
11.2 Middle East & Africa Sugammadex Sodium API Sales by Application (2017-2028)
11.3 Middle East & Africa Sugammadex Sodium API Market Size by Country
11.3.1 Middle East & Africa Sugammadex Sodium API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sugammadex Sodium API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Sugammadex Sodium API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sugammadex Sodium API
12.3 Sugammadex Sodium API Production Process
12.4 Sugammadex Sodium API Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sugammadex Sodium API Typical Distributors
13.3 Sugammadex Sodium API Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Sugammadex Sodium API Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sugammadex Sodium API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Transo-Pharm Basic Information, Manufacturing Base and Competitors
Table 4. Transo-Pharm Major Business
Table 5. Transo-Pharm Sugammadex Sodium API Product and Services
Table 6. Transo-Pharm Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Rochem International Basic Information, Manufacturing Base and Competitors
Table 8. Rochem International Major Business
Table 9. Rochem International Sugammadex Sodium API Product and Services
Table 10. Rochem International Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddy's Laboratories Major Business
Table 13. Dr. Reddy's Laboratories Sugammadex Sodium API Product and Services
Table 14. Dr. Reddy's Laboratories Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Extrovis AG Basic Information, Manufacturing Base and Competitors
Table 16. Extrovis AG Major Business
Table 17. Extrovis AG Sugammadex Sodium API Product and Services
Table 18. Extrovis AG Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Teva API Basic Information, Manufacturing Base and Competitors
Table 20. Teva API Major Business
Table 21. Teva API Sugammadex Sodium API Product and Services
Table 22. Teva API Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 24. Piramal Pharma Solutions Major Business
Table 25. Piramal Pharma Solutions Sugammadex Sodium API Product and Services
Table 26. Piramal Pharma Solutions Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. ASolution Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. ASolution Pharmaceuticals Major Business
Table 29. ASolution Pharmaceuticals Sugammadex Sodium API Product and Services
Table 30. ASolution Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BrightGene Bio-Medical Technology Basic Information, Manufacturing Base and Competitors
Table 32. BrightGene Bio-Medical Technology Major Business
Table 33. BrightGene Bio-Medical Technology Sugammadex Sodium API Product and Services
Table 34. BrightGene Bio-Medical Technology Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Epoch Labs Basic Information, Manufacturing Base and Competitors
Table 36. Epoch Labs Major Business
Table 37. Epoch Labs Sugammadex Sodium API Product and Services
Table 38. Epoch Labs Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lek Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Lek Pharmaceuticals Major Business
Table 41. Lek Pharmaceuticals Sugammadex Sodium API Product and Services
Table 42. Lek Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. MSN Laboratories Major Business
Table 45. MSN Laboratories Sugammadex Sodium API Product and Services
Table 46. MSN Laboratories Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Mankind Pharma Major Business
Table 49. Mankind Pharma Sugammadex Sodium API Product and Services
Table 50. Mankind Pharma Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Mylan Inc Basic Information, Manufacturing Base and Competitors
Table 52. Mylan Inc Major Business
Table 53. Mylan Inc Sugammadex Sodium API Product and Services
Table 54. Mylan Inc Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Solara Active Pharma Sciences Basic Information, Manufacturing Base and Competitors
Table 56. Solara Active Pharma Sciences Major Business
Table 57. Solara Active Pharma Sciences Sugammadex Sodium API Product and Services
Table 58. Solara Active Pharma Sciences Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Viwit Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Viwit Pharmaceuticals Major Business
Table 61. Viwit Pharmaceuticals Sugammadex Sodium API Product and Services
Table 62. Viwit Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Yonsung Fine Chemicals Basic Information, Manufacturing Base and Competitors
Table 64. Yonsung Fine Chemicals Major Business
Table 65. Yonsung Fine Chemicals Sugammadex Sodium API Product and Services
Table 66. Yonsung Fine Chemicals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Sugammadex Sodium API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 68. Global Sugammadex Sodium API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Sugammadex Sodium API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Sugammadex Sodium API Production Capacity by Company, (Tons): 2020 VS 2021
Table 71. Head Office and Sugammadex Sodium API Production Site of Key Manufacturer
Table 72. Sugammadex Sodium API New Entrant and Capacity Expansion Plans
Table 73. Sugammadex Sodium API Mergers & Acquisitions in the Past Five Years
Table 74. Global Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 75. Global Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 76. Global Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 79. Global Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 80. Global Sugammadex Sodium API Revenue by Purity (2017-2022) & (USD Million)
Table 81. Global Sugammadex Sodium API Revenue by Purity (2023-2028) & (USD Million)
Table 82. Global Sugammadex Sodium API Price by Purity (2017-2022) & (US$/Kg)
Table 83. Global Sugammadex Sodium API Price by Purity (2023-2028) & (US$/Kg)
Table 84. Global Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 85. Global Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 86. Global Sugammadex Sodium API Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Sugammadex Sodium API Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Sugammadex Sodium API Price by Application (2017-2022) & (US$/Kg)
Table 89. Global Sugammadex Sodium API Price by Application (2023-2028) & (US$/Kg)
Table 90. North America Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 91. North America Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 92. North America Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 95. North America Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 96. North America Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 97. North America Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 98. Europe Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 99. Europe Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 100. Europe Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 103. Europe Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 104. Europe Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 105. Europe Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 106. Asia-Pacific Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 107. Asia-Pacific Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 108. Asia-Pacific Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 111. Asia-Pacific Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 112. Asia-Pacific Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 113. Asia-Pacific Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 114. South America Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 115. South America Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 116. South America Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 119. South America Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 120. South America Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 121. South America Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 122. Middle East & Africa Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 123. Middle East & Africa Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 124. Middle East & Africa Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 127. Middle East & Africa Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 128. Middle East & Africa Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 129. Middle East & Africa Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 130. Sugammadex Sodium API Raw Material
Table 131. Key Manufacturers of Sugammadex Sodium API Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Sugammadex Sodium API Typical Distributors
Table 135. Sugammadex Sodium API Typical Customers
List of Figures
Figure 1. Sugammadex Sodium API Picture
Figure 2. Global Sugammadex Sodium API Revenue Market Share by Purity in 2021
Figure 3. 0.99
Figure 4. 0.995
Figure 5. Others
Figure 6. Global Sugammadex Sodium API Revenue Market Share by Application in 2021
Figure 7. Injection
Figure 8. Others
Figure 9. Global Sugammadex Sodium API Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global Sugammadex Sodium API Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Sugammadex Sodium API Sales (2017-2028) & (Tons)
Figure 12. Global Sugammadex Sodium API Price (2017-2028) & (US$/Kg)
Figure 13. Global Sugammadex Sodium API Production Capacity (2017-2028) & (Tons)
Figure 14. Global Sugammadex Sodium API Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Sugammadex Sodium API Market Drivers
Figure 16. Sugammadex Sodium API Market Restraints
Figure 17. Sugammadex Sodium API Market Trends
Figure 18. Global Sugammadex Sodium API Sales Market Share by Manufacturer in 2021
Figure 19. Global Sugammadex Sodium API Revenue Market Share by Manufacturer in 2021
Figure 20. Sugammadex Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Sugammadex Sodium API Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Sugammadex Sodium API Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 24. Global Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 25. North America Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 26. Europe Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 28. South America Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 30. Global Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 31. Global Sugammadex Sodium API Revenue Market Share by Purity (2017-2028)
Figure 32. Global Sugammadex Sodium API Price by Purity (2017-2028) & (US$/Kg)
Figure 33. Global Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 34. Global Sugammadex Sodium API Revenue Market Share by Application (2017-2028)
Figure 35. Global Sugammadex Sodium API Price by Application (2017-2028) & (US$/Kg)
Figure 36. North America Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 37. North America Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 38. North America Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 39. North America Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 40. United States Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 44. Europe Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 45. Europe Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 46. Europe Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 47. Germany Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 56. China Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 63. South America Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 64. South America Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 65. South America Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Sugammadex Sodium API in 2021
Figure 77. Manufacturing Process Analysis of Sugammadex Sodium API
Figure 78. Sugammadex Sodium API Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Transo-Pharm
Rochem International
Dr. Reddy's Laboratories
Extrovis AG
Teva API
Piramal Pharma Solutions
ASolution Pharmaceuticals
BrightGene Bio-Medical Technology
Epoch Labs
Lek Pharmaceuticals
MSN Laboratories
Mankind Pharma
Mylan Inc
Solara Active Pharma Sciences
Viwit Pharmaceuticals
Yonsung Fine Chemicals
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Sugammadex Sodium API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Sugammadex Sodium API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 119

Published Date: 04 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Sugammadex Sodium API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Sugammadex Sodium API market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Sugammadex Sodium API market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Injection occupied for % of the Sugammadex Sodium API global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, 0.99 segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Sugammadex Sodium API include Transo-Pharm, Rochem International, Dr. Reddy's Laboratories, Extrovis AG and Teva API, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Sugammadex Sodium API market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Sugammadex Sodium API manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Sugammadex Sodium API market based on the following parameters – headquarters, production locations, products portfolio, Sugammadex Sodium API revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Sugammadex Sodium API market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Sugammadex Sodium API market is split by Purity and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity (2017-2028; USD Million)
0.99
0.995
Others

Market segment by Application (2017-2028; USD Million)
Injection
Others

The key market players for global Sugammadex Sodium API market are listed below:
Transo-Pharm
Rochem International
Dr. Reddy's Laboratories
Extrovis AG
Teva API
Piramal Pharma Solutions
ASolution Pharmaceuticals
BrightGene Bio-Medical Technology
Epoch Labs
Lek Pharmaceuticals
MSN Laboratories
Mankind Pharma
Mylan Inc
Solara Active Pharma Sciences
Viwit Pharmaceuticals
Yonsung Fine Chemicals

Region Segment (2017-2028; USD Million)
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sugammadex Sodium API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sugammadex Sodium API, with price, sales, revenue and global market share of Sugammadex Sodium API from 2019 to 2022.
Chapter 3, the Sugammadex Sodium API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sugammadex Sodium API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sugammadex Sodium API market forecast, by regions, purity and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sugammadex Sodium API.
Chapter 13, 14, and 15, to describe Sugammadex Sodium API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Sugammadex Sodium API Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Sugammadex Sodium API Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 0.99
1.2.3 0.995
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sugammadex Sodium API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Injection
1.3.3 Others
1.4 Global Sugammadex Sodium API Market Size & Forecast
1.4.1 Global Sugammadex Sodium API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sugammadex Sodium API Sales in Volume (2017-2028)
1.4.3 Global Sugammadex Sodium API Price (2017-2028)
1.5 Global Sugammadex Sodium API Production Capacity Analysis
1.5.1 Global Sugammadex Sodium API Total Production Capacity (2017-2028)
1.5.2 Global Sugammadex Sodium API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sugammadex Sodium API Market Drivers
1.6.2 Sugammadex Sodium API Market Restraints
1.6.3 Sugammadex Sodium API Trends Analysis

2 Manufacturers Profiles
2.1 Transo-Pharm
2.1.1 Transo-Pharm Details
2.1.2 Transo-Pharm Major Business
2.1.3 Transo-Pharm Sugammadex Sodium API Product and Services
2.1.4 Transo-Pharm Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Rochem International
2.2.1 Rochem International Details
2.2.2 Rochem International Major Business
2.2.3 Rochem International Sugammadex Sodium API Product and Services
2.2.4 Rochem International Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dr. Reddy's Laboratories
2.3.1 Dr. Reddy's Laboratories Details
2.3.2 Dr. Reddy's Laboratories Major Business
2.3.3 Dr. Reddy's Laboratories Sugammadex Sodium API Product and Services
2.3.4 Dr. Reddy's Laboratories Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Extrovis AG
2.4.1 Extrovis AG Details
2.4.2 Extrovis AG Major Business
2.4.3 Extrovis AG Sugammadex Sodium API Product and Services
2.4.4 Extrovis AG Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva API
2.5.1 Teva API Details
2.5.2 Teva API Major Business
2.5.3 Teva API Sugammadex Sodium API Product and Services
2.5.4 Teva API Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Piramal Pharma Solutions
2.6.1 Piramal Pharma Solutions Details
2.6.2 Piramal Pharma Solutions Major Business
2.6.3 Piramal Pharma Solutions Sugammadex Sodium API Product and Services
2.6.4 Piramal Pharma Solutions Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ASolution Pharmaceuticals
2.7.1 ASolution Pharmaceuticals Details
2.7.2 ASolution Pharmaceuticals Major Business
2.7.3 ASolution Pharmaceuticals Sugammadex Sodium API Product and Services
2.7.4 ASolution Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BrightGene Bio-Medical Technology
2.8.1 BrightGene Bio-Medical Technology Details
2.8.2 BrightGene Bio-Medical Technology Major Business
2.8.3 BrightGene Bio-Medical Technology Sugammadex Sodium API Product and Services
2.8.4 BrightGene Bio-Medical Technology Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Epoch Labs
2.9.1 Epoch Labs Details
2.9.2 Epoch Labs Major Business
2.9.3 Epoch Labs Sugammadex Sodium API Product and Services
2.9.4 Epoch Labs Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lek Pharmaceuticals
2.10.1 Lek Pharmaceuticals Details
2.10.2 Lek Pharmaceuticals Major Business
2.10.3 Lek Pharmaceuticals Sugammadex Sodium API Product and Services
2.10.4 Lek Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MSN Laboratories
2.11.1 MSN Laboratories Details
2.11.2 MSN Laboratories Major Business
2.11.3 MSN Laboratories Sugammadex Sodium API Product and Services
2.11.4 MSN Laboratories Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mankind Pharma
2.12.1 Mankind Pharma Details
2.12.2 Mankind Pharma Major Business
2.12.3 Mankind Pharma Sugammadex Sodium API Product and Services
2.12.4 Mankind Pharma Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Mylan Inc
2.13.1 Mylan Inc Details
2.13.2 Mylan Inc Major Business
2.13.3 Mylan Inc Sugammadex Sodium API Product and Services
2.13.4 Mylan Inc Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Solara Active Pharma Sciences
2.14.1 Solara Active Pharma Sciences Details
2.14.2 Solara Active Pharma Sciences Major Business
2.14.3 Solara Active Pharma Sciences Sugammadex Sodium API Product and Services
2.14.4 Solara Active Pharma Sciences Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Viwit Pharmaceuticals
2.15.1 Viwit Pharmaceuticals Details
2.15.2 Viwit Pharmaceuticals Major Business
2.15.3 Viwit Pharmaceuticals Sugammadex Sodium API Product and Services
2.15.4 Viwit Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Yonsung Fine Chemicals
2.16.1 Yonsung Fine Chemicals Details
2.16.2 Yonsung Fine Chemicals Major Business
2.16.3 Yonsung Fine Chemicals Sugammadex Sodium API Product and Services
2.16.4 Yonsung Fine Chemicals Sugammadex Sodium API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Sugammadex Sodium API Breakdown Data by Manufacturer
3.1 Global Sugammadex Sodium API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sugammadex Sodium API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sugammadex Sodium API
3.4 Market Concentration Rate
3.4.1 Top 3 Sugammadex Sodium API Manufacturer Market Share in 2021
3.4.2 Top 6 Sugammadex Sodium API Manufacturer Market Share in 2021
3.5 Global Sugammadex Sodium API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sugammadex Sodium API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Sugammadex Sodium API Market Size by Region
4.1.1 Global Sugammadex Sodium API Sales in Volume by Region (2017-2028)
4.1.2 Global Sugammadex Sodium API Revenue by Region (2017-2028)
4.2 North America Sugammadex Sodium API Revenue (2017-2028)
4.3 Europe Sugammadex Sodium API Revenue (2017-2028)
4.4 Asia-Pacific Sugammadex Sodium API Revenue (2017-2028)
4.5 South America Sugammadex Sodium API Revenue (2017-2028)
4.6 Middle East and Africa Sugammadex Sodium API Revenue (2017-2028)

5 Market Segment by Purity
5.1 Global Sugammadex Sodium API Sales in Volume by Purity (2017-2028)
5.2 Global Sugammadex Sodium API Revenue by Purity (2017-2028)
5.3 Global Sugammadex Sodium API Price by Purity (2017-2028)

6 Market Segment by Application
6.1 Global Sugammadex Sodium API Sales in Volume by Application (2017-2028)
6.2 Global Sugammadex Sodium API Revenue by Application (2017-2028)
6.3 Global Sugammadex Sodium API Price by Application (2017-2028)

7 North America by Country, by Purity, and by Application
7.1 North America Sugammadex Sodium API Sales by Purity (2017-2028)
7.2 North America Sugammadex Sodium API Sales by Application (2017-2028)
7.3 North America Sugammadex Sodium API Market Size by Country
7.3.1 North America Sugammadex Sodium API Sales in Volume by Country (2017-2028)
7.3.2 North America Sugammadex Sodium API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Purity, and by Application
8.1 Europe Sugammadex Sodium API Sales by Purity (2017-2028)
8.2 Europe Sugammadex Sodium API Sales by Application (2017-2028)
8.3 Europe Sugammadex Sodium API Market Size by Country
8.3.1 Europe Sugammadex Sodium API Sales in Volume by Country (2017-2028)
8.3.2 Europe Sugammadex Sodium API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Purity, and by Application
9.1 Asia-Pacific Sugammadex Sodium API Sales by Purity (2017-2028)
9.2 Asia-Pacific Sugammadex Sodium API Sales by Application (2017-2028)
9.3 Asia-Pacific Sugammadex Sodium API Market Size by Region
9.3.1 Asia-Pacific Sugammadex Sodium API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sugammadex Sodium API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Purity, and by Application
10.1 South America Sugammadex Sodium API Sales by Purity (2017-2028)
10.2 South America Sugammadex Sodium API Sales by Application (2017-2028)
10.3 South America Sugammadex Sodium API Market Size by Country
10.3.1 South America Sugammadex Sodium API Sales in Volume by Country (2017-2028)
10.3.2 South America Sugammadex Sodium API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Purity, and by Application
11.1 Middle East & Africa Sugammadex Sodium API Sales by Purity (2017-2028)
11.2 Middle East & Africa Sugammadex Sodium API Sales by Application (2017-2028)
11.3 Middle East & Africa Sugammadex Sodium API Market Size by Country
11.3.1 Middle East & Africa Sugammadex Sodium API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sugammadex Sodium API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Sugammadex Sodium API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sugammadex Sodium API
12.3 Sugammadex Sodium API Production Process
12.4 Sugammadex Sodium API Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sugammadex Sodium API Typical Distributors
13.3 Sugammadex Sodium API Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Sugammadex Sodium API Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sugammadex Sodium API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Transo-Pharm Basic Information, Manufacturing Base and Competitors
Table 4. Transo-Pharm Major Business
Table 5. Transo-Pharm Sugammadex Sodium API Product and Services
Table 6. Transo-Pharm Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Rochem International Basic Information, Manufacturing Base and Competitors
Table 8. Rochem International Major Business
Table 9. Rochem International Sugammadex Sodium API Product and Services
Table 10. Rochem International Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddy's Laboratories Major Business
Table 13. Dr. Reddy's Laboratories Sugammadex Sodium API Product and Services
Table 14. Dr. Reddy's Laboratories Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Extrovis AG Basic Information, Manufacturing Base and Competitors
Table 16. Extrovis AG Major Business
Table 17. Extrovis AG Sugammadex Sodium API Product and Services
Table 18. Extrovis AG Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Teva API Basic Information, Manufacturing Base and Competitors
Table 20. Teva API Major Business
Table 21. Teva API Sugammadex Sodium API Product and Services
Table 22. Teva API Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 24. Piramal Pharma Solutions Major Business
Table 25. Piramal Pharma Solutions Sugammadex Sodium API Product and Services
Table 26. Piramal Pharma Solutions Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. ASolution Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. ASolution Pharmaceuticals Major Business
Table 29. ASolution Pharmaceuticals Sugammadex Sodium API Product and Services
Table 30. ASolution Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BrightGene Bio-Medical Technology Basic Information, Manufacturing Base and Competitors
Table 32. BrightGene Bio-Medical Technology Major Business
Table 33. BrightGene Bio-Medical Technology Sugammadex Sodium API Product and Services
Table 34. BrightGene Bio-Medical Technology Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Epoch Labs Basic Information, Manufacturing Base and Competitors
Table 36. Epoch Labs Major Business
Table 37. Epoch Labs Sugammadex Sodium API Product and Services
Table 38. Epoch Labs Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lek Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Lek Pharmaceuticals Major Business
Table 41. Lek Pharmaceuticals Sugammadex Sodium API Product and Services
Table 42. Lek Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. MSN Laboratories Major Business
Table 45. MSN Laboratories Sugammadex Sodium API Product and Services
Table 46. MSN Laboratories Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Mankind Pharma Major Business
Table 49. Mankind Pharma Sugammadex Sodium API Product and Services
Table 50. Mankind Pharma Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Mylan Inc Basic Information, Manufacturing Base and Competitors
Table 52. Mylan Inc Major Business
Table 53. Mylan Inc Sugammadex Sodium API Product and Services
Table 54. Mylan Inc Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Solara Active Pharma Sciences Basic Information, Manufacturing Base and Competitors
Table 56. Solara Active Pharma Sciences Major Business
Table 57. Solara Active Pharma Sciences Sugammadex Sodium API Product and Services
Table 58. Solara Active Pharma Sciences Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Viwit Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Viwit Pharmaceuticals Major Business
Table 61. Viwit Pharmaceuticals Sugammadex Sodium API Product and Services
Table 62. Viwit Pharmaceuticals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Yonsung Fine Chemicals Basic Information, Manufacturing Base and Competitors
Table 64. Yonsung Fine Chemicals Major Business
Table 65. Yonsung Fine Chemicals Sugammadex Sodium API Product and Services
Table 66. Yonsung Fine Chemicals Sugammadex Sodium API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Sugammadex Sodium API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 68. Global Sugammadex Sodium API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Sugammadex Sodium API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Sugammadex Sodium API Production Capacity by Company, (Tons): 2020 VS 2021
Table 71. Head Office and Sugammadex Sodium API Production Site of Key Manufacturer
Table 72. Sugammadex Sodium API New Entrant and Capacity Expansion Plans
Table 73. Sugammadex Sodium API Mergers & Acquisitions in the Past Five Years
Table 74. Global Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 75. Global Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 76. Global Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 79. Global Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 80. Global Sugammadex Sodium API Revenue by Purity (2017-2022) & (USD Million)
Table 81. Global Sugammadex Sodium API Revenue by Purity (2023-2028) & (USD Million)
Table 82. Global Sugammadex Sodium API Price by Purity (2017-2022) & (US$/Kg)
Table 83. Global Sugammadex Sodium API Price by Purity (2023-2028) & (US$/Kg)
Table 84. Global Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 85. Global Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 86. Global Sugammadex Sodium API Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Sugammadex Sodium API Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Sugammadex Sodium API Price by Application (2017-2022) & (US$/Kg)
Table 89. Global Sugammadex Sodium API Price by Application (2023-2028) & (US$/Kg)
Table 90. North America Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 91. North America Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 92. North America Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 95. North America Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 96. North America Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 97. North America Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 98. Europe Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 99. Europe Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 100. Europe Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 103. Europe Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 104. Europe Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 105. Europe Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 106. Asia-Pacific Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 107. Asia-Pacific Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 108. Asia-Pacific Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 111. Asia-Pacific Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 112. Asia-Pacific Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 113. Asia-Pacific Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 114. South America Sugammadex Sodium API Sales by Country (2017-2022) & (Tons)
Table 115. South America Sugammadex Sodium API Sales by Country (2023-2028) & (Tons)
Table 116. South America Sugammadex Sodium API Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Sugammadex Sodium API Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 119. South America Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 120. South America Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 121. South America Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 122. Middle East & Africa Sugammadex Sodium API Sales by Region (2017-2022) & (Tons)
Table 123. Middle East & Africa Sugammadex Sodium API Sales by Region (2023-2028) & (Tons)
Table 124. Middle East & Africa Sugammadex Sodium API Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Sugammadex Sodium API Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Sugammadex Sodium API Sales by Purity (2017-2022) & (Tons)
Table 127. Middle East & Africa Sugammadex Sodium API Sales by Purity (2023-2028) & (Tons)
Table 128. Middle East & Africa Sugammadex Sodium API Sales by Application (2017-2022) & (Tons)
Table 129. Middle East & Africa Sugammadex Sodium API Sales by Application (2023-2028) & (Tons)
Table 130. Sugammadex Sodium API Raw Material
Table 131. Key Manufacturers of Sugammadex Sodium API Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Sugammadex Sodium API Typical Distributors
Table 135. Sugammadex Sodium API Typical Customers
List of Figures
Figure 1. Sugammadex Sodium API Picture
Figure 2. Global Sugammadex Sodium API Revenue Market Share by Purity in 2021
Figure 3. 0.99
Figure 4. 0.995
Figure 5. Others
Figure 6. Global Sugammadex Sodium API Revenue Market Share by Application in 2021
Figure 7. Injection
Figure 8. Others
Figure 9. Global Sugammadex Sodium API Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global Sugammadex Sodium API Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Sugammadex Sodium API Sales (2017-2028) & (Tons)
Figure 12. Global Sugammadex Sodium API Price (2017-2028) & (US$/Kg)
Figure 13. Global Sugammadex Sodium API Production Capacity (2017-2028) & (Tons)
Figure 14. Global Sugammadex Sodium API Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Sugammadex Sodium API Market Drivers
Figure 16. Sugammadex Sodium API Market Restraints
Figure 17. Sugammadex Sodium API Market Trends
Figure 18. Global Sugammadex Sodium API Sales Market Share by Manufacturer in 2021
Figure 19. Global Sugammadex Sodium API Revenue Market Share by Manufacturer in 2021
Figure 20. Sugammadex Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Sugammadex Sodium API Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Sugammadex Sodium API Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 24. Global Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 25. North America Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 26. Europe Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 28. South America Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Sugammadex Sodium API Revenue (2017-2028) & (USD Million)
Figure 30. Global Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 31. Global Sugammadex Sodium API Revenue Market Share by Purity (2017-2028)
Figure 32. Global Sugammadex Sodium API Price by Purity (2017-2028) & (US$/Kg)
Figure 33. Global Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 34. Global Sugammadex Sodium API Revenue Market Share by Application (2017-2028)
Figure 35. Global Sugammadex Sodium API Price by Application (2017-2028) & (US$/Kg)
Figure 36. North America Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 37. North America Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 38. North America Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 39. North America Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 40. United States Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 44. Europe Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 45. Europe Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 46. Europe Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 47. Germany Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 56. China Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 63. South America Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 64. South America Sugammadex Sodium API Sales Market Share by Country (2017-2028)
Figure 65. South America Sugammadex Sodium API Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Sugammadex Sodium API Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Sugammadex Sodium API Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Sugammadex Sodium API Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Sugammadex Sodium API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Sugammadex Sodium API in 2021
Figure 77. Manufacturing Process Analysis of Sugammadex Sodium API
Figure 78. Sugammadex Sodium API Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Transo-Pharm
Rochem International
Dr. Reddy's Laboratories
Extrovis AG
Teva API
Piramal Pharma Solutions
ASolution Pharmaceuticals
BrightGene Bio-Medical Technology
Epoch Labs
Lek Pharmaceuticals
MSN Laboratories
Mankind Pharma
Mylan Inc
Solara Active Pharma Sciences
Viwit Pharmaceuticals
Yonsung Fine Chemicals
jiaGou

Add To Cart

gouMai

Buy Now